author-photo

Audrey H. Lau

University of Pittsburgh

32

Papers

1080

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

2020 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (37)
O-12 : Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients with Moderate or Severe Renal Impairment, or in End-Stage Renal Disease (ESRD) Patients on Hemodialysis (HD): Week 2

2020
Show All
- Source
- Cite
- Save
Citations (0)
Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjects.

2020 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (5)
O-13 : Switching from Tenofovir Disoproxil Fumarate (TDF) or Other Oral Antiviral Therapy (OAV) to Tenofovir Alafenamide (TAF) in Virally Suppressed CHB Patients with Hepatic Impairment

2020
Show All
- Source
- Cite
- Save
Citations (0)
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (52)
Safety, Pharmacokinetics and Pharmacodynamics of Oral TLR8 Agonist GS-9688 in Patients with Chronic Hepatitis B: A Randomized, Placebo-Controlled, Double-Blind Phase 1b Study

2018 Hepatology
Show All
- Source
- Cite
- Save
Citations (3)
PO-026 : Improvement in Renal Parameters in CHB Patients Treated with Tenofovir Alfenamide (TAF) versus Tenofovir Disoproxil Fumarate (TDF) over 96 Weeks

2017
Show All
- Source
- Cite
- Save
Citations (0)
POSTER PRESENTATIONS: Posters Friday, 21 April 2017: Viral hepatitis: Hepatitis B and D – Clinical (therapy, new compounds, resistance)FRI-153 - A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96

2017 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (16)
PO-022 : Viral Kinetics in Women of Child Bearing Potential with Chronic HBV Following Treatment with Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate

2017
Show All
- Source
- Cite
- Save
Citations (0)
Posttransplant metabolic syndrome in children and adolescents after liver transplantation: A systematic review†

2012 Liver Transplantation
Show All
- Source
- Cite
- Save
Citations (38)